A phase 2 trial of burosumab for treatment of fibroblast growth factor-23-mediated hypophosphatemia in children and adults with fibrous dysplasia. [PDF]
de Jong O +9 more
europepmc +1 more source
Hypophosphatemia as a biomarker of metabolic intolerance to enhanced nutrition in the PICU: a secondary analysis of the PEPaNIC RCT. [PDF]
Vanhorebeek I +7 more
europepmc +1 more source
Refeeding Syndrome May Increase the Risk of Anemia of Prematurity: Is Early Enteral Nutrition the Solution? [PDF]
Di Chiara M +7 more
europepmc +1 more source
Genetic background of infantile hypophosphatemia: a narrative review. [PDF]
Zeng X, Hu L.
europepmc +1 more source
Admission Electrolyte Abnormalities and Clinical Outcomes in Hospitalized COVID-19 Patients. [PDF]
Önder E +6 more
europepmc +1 more source
The Significance of Hypophosphatemia in Deciding on an Optimal Clinical Choice of Parenteral Iron Therapy in Patients with Chronic Inflammatory Bowel Disease in Slovenia: An Umbrella Review and Economic Evaluation. [PDF]
Hren R, Dóczi T, Országh E, Kocjan T.
europepmc +1 more source
XLH Matters 2024 GCC Edition: Insights and Recommendations to Improve Outcomes for People Living With XLH in the Gulf Region. [PDF]
Seefried L +10 more
europepmc +1 more source
Management of X-Linked Hypophosphatemia During Pregnancy: Case Report and Literature Review. [PDF]
Arcidiacono GP +10 more
europepmc +1 more source
Phosphaturic mesenchymal tumor in the temporalis muscle causing tumor-induced osteomalacia: a case report and literature review. [PDF]
Gao B, Wang C, Xu X, Lai X, Xu X.
europepmc +1 more source

